Early Initiation of Tolvaptan is Associated with Early Discharge in Elderly Heart Failure Patients

por Kiuchi, Shunsuke, Hisatake, Shinji, Murakami, Yoshiki, Sano, Takahide, Ikeda, Takanori
Publicado 2021

Early initiation of tolvaptan is associated with early discharge in patients with heart failure regardless of age

por Kiuchi, Shunsuke, Hisatake, Shinji, Kabuki, Takayuki, Oka, Takashi, Dobashi, Shintaro, Murakami, Yoshiki, Sano, Takahide, Ikeda, Takanori
Publicado 2022

Predictive value of neutrophil-to-lymphocyte ratio for the fatality of COVID-19 patients complicated with cardiovascular diseases and/or risk factors

por Higaki, Akinori, Okayama, Hideki, Homma, Yoshito, Sano, Takahide, Kitai, Takeshi, Yonetsu, Taishi, Torii, Sho, Kohsaka, Shun, Kuroda, Shunsuke, Node, Koichi, Matsue, Yuya, Matsumoto, Shingo
Publicado 2022

External validation of the 4C Mortality Score for patients with COVID-19 and pre-existing cardiovascular diseases/risk factors

por Kuroda, Shunsuke, Matsumoto, Shingo, Sano, Takahide, Kitai, Takeshi, Yonetsu, Taishi, Kohsaka, Shun, Torii, Sho, Kishi, Takuya, Komuro, Issei, Hirata, Ken-ichi, Node, Koichi, Matsue, Yuya
Publicado 2021

Assessment of thromboembolism risk in COVID-19 patients with cardiovascular disease risk factors: Analysis of a Japanese Nationwide Registry()

por Shibahashi, Eiji, Jujo, Kentaro, Kuroda, Shunsuke, Matsumoto, Shingo, Sano, Takahide, Kitai, Takeshi, Yonetsu, Taishi, Kohsaka, Shun, Torii, Sho, Yamaguchi, Tetsuo, Kishi, Takuya, Komuro, Issei, Hirata, Kenichi, Node, Koichi, Matsue, Yuya
Publicado 2022

Intensive Care Unit Admission for Moderate-to-Severe COVID-19 Patients With Known Cardiovascular Diseases or Their Risk Factors　― Insights From a Nationwide Japanese Cohort Study ―...

por Yoshida, Naofumi, Iwata, Sachiyo, Ogawa, Masato, Izawa, Kazuhiro P., Kuroda, Shunsuke, Kohsaka, Shun, Yonetsu, Taishi, Kitai, Takeshi, Torii, Sho, Sano, Takahide, Sakai, Yoshitada, Yamashita, Tomoya, Hirata, Ken-ichi, Matsue, Yuya, Matsumoto, Shingo, Node, Koichi
Publicado 2021